Abstract
Thionamides (such as thiamazole/methimazole) are a common first line treatment for Graves' disease. Common side effects include rash, urticaria, and arthralgia. However, thionamide treatment has also been associated with a variety of auto-immune syndromes. Here, we describe a patient presenting with mild arthritis after starting thiamazole. Although severe presentation warrants acute withdrawal of the causative agent, our case suggests that milder forms can be successfully treated with anti-inflammatory drugs alone. Recognition of the syndrome is key to warrant timely and effective treatment.
Original language | English |
---|---|
Pages (from-to) | 389-391 |
Number of pages | 3 |
Journal | Netherlands Journal of Medicine |
Volume | 78 |
Issue number | 6 |
Publication status | Published - Dec 2020 |
Keywords
- Arthritis
- auto-immune
- Graves' disease
- methimazole
- thiamazole
- thionamides